INVIVO THERAPEUTICS HOLDINGS CORP. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/28519926-ae77-41ba-9da9-046f12315f02/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-10.5M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-002588 |
| FY 2021 | $-9.9M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002957 |
| FY 2020 | $-9.1M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002156 |
| FY 2019 | $-11.8M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-001077 |
| FY 2018 | $-23.4M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-002671 |
| FY 2017 | $-26.7M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001864 |
| FY 2016 | $-23.4M | 2016-01-01 – 2016-12-31 | evidence 0001558370-18-001864 |
| FY 2015 | $-33.3M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010780 |
| FY 2014 | $-18.3M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001983 |
| FY 2013 | $-87.0M | 2005-11-29 – 2014-03-31 | evidence 0001104659-14-037599 |
| FY 2012 | $-56.5M | 2005-11-29 – 2013-03-31 | evidence 0001193125-13-208945 |
| FY 2011 | $-44.7M | 2005-11-28 – 2012-03-31 | evidence 0001193125-12-231433 |
| FY 2010 | $-7.9M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-116041 |
| FY 2009 | $-2.5M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-116041 |
| FY 2008 | $-1.6M | 2008-01-01 – 2008-12-31 | evidence 0001193125-12-116041 |
| FY 2007 | $-1.1M | 2005-11-29 – 2007-12-31 | evidence 0001193125-13-103355 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INVIVO THERAPEUTICS HOLDINGS CORP. — all facts · Operating Income